Home › Neurologic Diseases › Texas › Austin
Neurologic Diseases clinical trials in Austin, TX
5 studies for Neurologic Diseases are looking for participants at sites in and around Austin (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
RecruitingPhase 2
- Clinical Site, Austin
A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence
RecruitingPhase 2/3
- Austin, Texas, Austin
Product Surveillance Registry
RecruitingObservational study
- Austin, Austin
- Kyle, Kyle · 21 mi away
A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
RecruitingPhase 2
- Clinical Site, Austin
Music-4-MS to Improve Cognition in People Living With Multiple Sclerosis: A Feasibility Study
Recruiting
- University of Texas at Austin, Austin
About Neurologic Diseases
Your nervous system includes your brain, spinal cord, and nerves. Learn about neurologic diseases, including their symptoms, causes, and treatments.
More about Neurologic Diseases on MedlinePlus
Neurologic Diseases trials in other cities
- Boston, MA10 studies
- Orlando, FL7 studies
- Miami, FL7 studies
- Washington, DC7 studies
- Philadelphia, PA7 studies
- Dallas, TX7 studies
- Houston, TX7 studies
- San Diego, CA6 studies
- St. Louis, MO6 studies
- New York City, NY5 studies
- Los Angeles, CA5 studies
- Chicago, IL5 studies
Other studies in Austin
- Non-Small Cell Lung Cancer29 studies
- Cancer (all types)22 studies
- Obesity22 studies
- Overweight19 studies
- Metastatic Cancer18 studies
- Colorectal Cancer17 studies
- Ovarian Cancer17 studies
- Heart Failure17 studies
- Endometrial Cancer15 studies
- Breast Cancer15 studies
- Type 2 Diabetes14 studies
- Prostate Cancer14 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.